Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Trehalose

EU orphan designation number: EU/3/15/1496   
Active ingredient: Trehalose
Indication: Treatment of oculopharyngeal muscular dystrophy
Sponsor: Dr Ulrich Granzer
Mauerkircherstraße 105, 81925 München, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
26/05/2015 Orphan designation EMA/OD/008/15 (2015)3576 of 21/05/2015